Seagen Inc.
GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF
Last updated:
Abstract:
The invention provides murine, chimeric, and humanized antibodies that specifically bind to GPC3 and conjugates thereof.
Status:
Application
Type:
Utility
Filling date:
15 Feb 2019
Issue date:
25 Nov 2021